Study of Monochromatic X-ray Mammography System
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Imagine Scientific, Inc.
- Study ID
- NCT07219797
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Breast Cancer
- Breast Imaging
Eligibility Criteria
- Sex
- FEMALE
- Age
- 40 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 2-D Monochromatic X-ray Mammography System — DEVICEMonochromatic x-ray mammography system produces superior images as compared to conventional 2-D and 3-D mammography while using a lower radiation dose.
Study Details
A research study to find out if an investigational mammography machine is effective in producing high-quality images using a lower radiation dose than traditional mammography.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Oct 2025
- Primary completion
- Mar 31, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SCREENING
Arms
- Experimental: Test device vs standard of careDemonstrate that a 2-D monochromatic x-ray mammography system can produce mammographic images using lower radiation dose, yet not inferior to conventional mammography.
Primary Outcome Measure
Noninferiority of a 2-D monochromatic X-ray mammography system compared to conventional mammography [ Time Frame: Enrollment to end of visit 1 (or up to 7 days following visit 1, if needed) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke Cancer Center | Durham | North Carolina | 27710 | Lars Grimm, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Durham, NC
By condition
By specialty
By research site
Related Studies
- Correlation of Molecular Markers With Response to Therapy and Breast Cancer BehaviorRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama